BioatlaInc Total Current Liabilities from 2010 to 2024

BCAB Stock  USD 2.35  0.11  4.91%   
BioatlaInc's Total Current Liabilities is increasing over the years with slightly volatile fluctuation. Total Current Liabilities is expected to dwindle to about 25.6 M. Total Current Liabilities is the total amount of liabilities that BioatlaInc is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. View All Fundamentals
 
Total Current Liabilities  
First Reported
2010-12-31
Previous Quarter
28.3 M
Current Value
25.6 M
Quarterly Volatility
8.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioatlaInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioatlaInc main balance sheet or income statement drivers, such as Net Interest Income of 6 M, Interest Income of 6 M or Depreciation And Amortization of 1.4 M, as well as many exotic indicators such as Price To Sales Ratio of 2.6 K, Dividend Yield of 0.0 or PTB Ratio of 1.75. BioatlaInc financial statements analysis is a perfect complement when working with BioatlaInc Valuation or Volatility modules.
  
This module can also supplement BioatlaInc's financial leverage analysis and stock options assessment as well as various BioatlaInc Technical models . Check out the analysis of BioatlaInc Correlation against competitors.
For information on how to trade BioatlaInc Stock refer to our How to Trade BioatlaInc Stock guide.

Latest BioatlaInc's Total Current Liabilities Growth Pattern

Below is the plot of the Total Current Liabilities of BioatlaInc over the last few years. Total Current Liabilities is an item on BioatlaInc balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of BioatlaInc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. BioatlaInc's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioatlaInc's overall financial position and show how it may be relating to other accounts over time.
Total Current Liabilities10 Years Trend
Slightly volatile
   Total Current Liabilities   
       Timeline  

BioatlaInc Total Current Liabilities Regression Statistics

Arithmetic Mean15,906,614
Geometric Mean13,865,810
Coefficient Of Variation55.86
Mean Deviation8,052,737
Median9,196,000
Standard Deviation8,884,697
Sample Variance78.9T
Range23.1M
R-Value0.80
Mean Square Error30.4T
R-Squared0.64
Significance0.0003
Slope1,592,413
Total Sum of Squares1105.1T

BioatlaInc Total Current Liabilities History

202425.6 M
202328.3 M
202223.1 M
202119.8 M
202032.3 M
201926.7 M

About BioatlaInc Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include BioatlaInc income statement, its balance sheet, and the statement of cash flows. BioatlaInc investors use historical funamental indicators, such as BioatlaInc's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although BioatlaInc investors may use each financial statement separately, they are all related. The changes in BioatlaInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on BioatlaInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on BioatlaInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in BioatlaInc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Current Liabilities28.3 M25.6 M

Pair Trading with BioatlaInc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioatlaInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioatlaInc will appreciate offsetting losses from the drop in the long position's value.

Moving together with BioatlaInc Stock

  0.61VKTX Viking Therapeutics Potential GrowthPairCorr
  0.7ELEV Elevation Oncology Earnings Call This WeekPairCorr

Moving against BioatlaInc Stock

  0.47GILD Gilead Sciences Earnings Call TodayPairCorr
The ability to find closely correlated positions to BioatlaInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioatlaInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioatlaInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioatlaInc to buy it.
The correlation of BioatlaInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioatlaInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioatlaInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioatlaInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether BioatlaInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioatlaInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioatlainc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioatlainc Stock:
Check out the analysis of BioatlaInc Correlation against competitors.
For information on how to trade BioatlaInc Stock refer to our How to Trade BioatlaInc Stock guide.
Note that the BioatlaInc information on this page should be used as a complementary analysis to other BioatlaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Complementary Tools for BioatlaInc Stock analysis

When running BioatlaInc's price analysis, check to measure BioatlaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioatlaInc is operating at the current time. Most of BioatlaInc's value examination focuses on studying past and present price action to predict the probability of BioatlaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioatlaInc's price. Additionally, you may evaluate how the addition of BioatlaInc to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Is BioatlaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioatlaInc. If investors know BioatlaInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioatlaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.58)
Quarterly Revenue Growth
0.316
Return On Assets
(0.47)
Return On Equity
(0.98)
The market value of BioatlaInc is measured differently than its book value, which is the value of BioatlaInc that is recorded on the company's balance sheet. Investors also form their own opinion of BioatlaInc's value that differs from its market value or its book value, called intrinsic value, which is BioatlaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioatlaInc's market value can be influenced by many factors that don't directly affect BioatlaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioatlaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioatlaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioatlaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.